INDICAID® COVID-19 Rapid Antigen Test Kit

$999,999.00 HKD
Specifications: Individual Kit
Individual Kit
2-kits | TW2 | Product Code: P0038
2-kits | NZ | Product Code: P0038
12-kits | TW2 | Product Code: P0040
12-kits | NZ | Product Code: P0040
1 Able to detect coronavirus variants
- Detectable variants include Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2), Delta Plus (AY.1 and AY.2), and Omicron (B.1.1.529)

- INDICAID®️ COVID-19 Rapid Antigen Test obtained U.S. FDA EUA in July 2021

Orders & Delivery
  1. Orders are normally expected to be delivered within 5 working days. You will be notified via SMS upon the arrival of your product. Exact delivery time may differ subjecting to the order volume
  2. Sales and shipping only available in Hong Kong
  3. Delivery service is currently not available for the Outlying Islands
  4. Shipping fee is not included


How to interpret the results?
Negative: A line appears in the region (C)
Positive: A line appears in regions (C) and (T)
Invalid Result: No line appears in the region (C)

Positive Result: Please contact us via our customer service hotline at 3700 8888, from 10:00 8:00 p.m. (Mon-Sun). We will provide further guidelines with regards to your situation.
Negative Result: Regular testing (at least once every week) is recommended. If you have had contact with a known or suspected COVID-19 case, you are recommended to take a PCR test.

Is the results accurate?
The accuracy of COVID-19 Antigen Tests is measured under two metrics.
  • Sensitivity: Measures the ability to correctly identify positive patient samples. If a test kit has a high sensitivity, it means that the kit has a high positive percentage agreement and a low false negative rate
  • Specificity: Measures the ability to correctly identify negative patient samples. If a test kit has a high specificity, it means that the kit has a high negative percentage agreement and a low false positive rate
INDICAID®'s overall sensitivity and specificity is 96% and 99% respectively, and is able to detect the presence of certain COVID-19 variants.
Has INDICAID®️ gone through any clinical validation?
INDICAID® has passed extensive clinical validation. In Hong Kong Government’s Community Testing Scheme, INDICAID®has been used as part of the dual-track testing scheme along with COVID-19 PCR tests. As of January 2021, after the completion of 22994 clinical tests, it has been shown to reach accuracy comparable to PCR tests. This is the world's largest clinical study for a product of its kind.